However, when cholesterol efflux was normalised to apoA-I15, subjects who developed T2DM presented lower cholesterol efflux/apoA-I ratio than subjects that remained non-diabetic during follow-up (Table 2 and Fig. 1). This evidence concerns the gene APOA1 and type 2 diabetes mellitus.